THOMAS, Astrid Maria
 Distribuzione geografica
Continente #
NA - Nord America 9.380
EU - Europa 7.923
AS - Asia 6.433
SA - Sud America 946
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 16
Totale 24.806
Nazione #
US - Stati Uniti d'America 9.215
SG - Singapore 2.391
CN - Cina 2.190
IT - Italia 1.668
UA - Ucraina 1.365
IE - Irlanda 1.135
GB - Regno Unito 949
TR - Turchia 875
BR - Brasile 776
SE - Svezia 704
FR - Francia 679
DE - Germania 547
IN - India 334
VN - Vietnam 320
FI - Finlandia 319
RU - Federazione Russa 225
CA - Canada 95
AR - Argentina 59
NL - Olanda 56
PL - Polonia 55
MX - Messico 54
JP - Giappone 49
BD - Bangladesh 42
HK - Hong Kong 42
ES - Italia 39
AT - Austria 32
ZA - Sudafrica 32
CZ - Repubblica Ceca 31
EC - Ecuador 27
LU - Lussemburgo 24
IQ - Iraq 23
IR - Iran 23
KR - Corea 23
BE - Belgio 20
CO - Colombia 20
EU - Europa 20
PK - Pakistan 18
ID - Indonesia 17
MA - Marocco 17
CH - Svizzera 16
VE - Venezuela 16
CL - Cile 14
LT - Lituania 12
PE - Perù 12
RO - Romania 12
UZ - Uzbekistan 12
EG - Egitto 11
IL - Israele 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
KE - Kenya 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
GR - Grecia 6
JO - Giordania 6
PY - Paraguay 6
UY - Uruguay 6
AZ - Azerbaigian 5
BO - Bolivia 5
DK - Danimarca 5
LB - Libano 5
MY - Malesia 5
SA - Arabia Saudita 5
TN - Tunisia 5
GY - Guiana 4
KZ - Kazakistan 4
PH - Filippine 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
NP - Nepal 3
SI - Slovenia 3
SM - San Marino 3
AM - Armenia 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
GD - Grenada 1
GH - Ghana 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
Totale 24.795
Città #
Singapore 1.768
Jacksonville 1.494
Chandler 1.333
Dublin 1.119
Southend 690
Princeton 567
Dallas 482
Ashburn 481
Beijing 481
Izmir 453
Nanjing 442
Wilmington 298
Dearborn 260
Los Angeles 249
Cambridge 241
Santa Clara 207
Tongling 183
Altamura 162
The Dalles 156
Nanchang 148
Buffalo 141
New York 125
Chieti 123
Munich 116
Ann Arbor 114
Woodbridge 108
Ho Chi Minh City 106
Boardman 93
Rome 89
Shenyang 84
São Paulo 82
Hebei 76
Redondo Beach 71
Tianjin 70
Milan 67
Jiaxing 61
Houston 60
Council Bluffs 56
Grevenbroich 53
Hanoi 52
Hefei 51
Helsinki 51
Kunming 49
Pescara 45
Washington 45
London 41
Norwalk 41
Hong Kong 40
Brooklyn 39
Changsha 37
Hangzhou 37
Warsaw 37
Toronto 36
Jinan 34
Orem 32
Tokyo 32
Chennai 29
Turku 29
Denver 28
Lanzhou 28
Atlanta 27
Stockholm 27
Montreal 26
Chicago 24
Belo Horizonte 23
Florence 23
Dong Ket 21
Naples 21
Rio de Janeiro 21
Augusta 20
Johannesburg 20
Seoul 20
Changchun 19
Orange 19
Poplar 19
Ardabil 18
Biên Hòa 18
Falls Church 18
Mexico City 18
Ningbo 18
Taizhou 18
Frankfurt am Main 17
Haiphong 17
Manchester 17
Brno 16
Dudelange 16
Nuremberg 16
Phoenix 16
San Francisco 16
Boston 15
Brussels 14
Paris 14
Charlotte 13
Guangzhou 13
Mumbai 13
Seattle 13
Zhengzhou 13
Ancona 12
Brasília 12
Leawood 12
Totale 14.435
Nome #
Emergenza neurologica - tempesta distonica: diagnosi e terapia 468
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 336
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 300
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 267
Pre-trattamento antiematico per Test/terapia all'apomorfina 181
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 158
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 155
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 151
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 150
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 144
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 143
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 143
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 142
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 140
Akinetic crisis in Dementia with Lewy Bodies 137
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 136
Progetto atrofia multisistemica: risultati preliminari. 136
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 135
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 134
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 133
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 131
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 130
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 129
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 127
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 126
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 125
Bipallidal lesions induce delayed and progressive parkinsonism 125
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 125
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 124
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 123
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 122
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 120
Attention network in AD and DLB patients: a resting fMRI study. 120
Improving diagnostic accuracy of DLB: An MRI study 120
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 119
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 119
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 119
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 118
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 118
Autoscopic phenomena: case report and review of literature. 116
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 115
Amantadine for dyskinesia in patients affected by severe Parkinson's disease. 115
Acute akinesia or akinetic crisis in Parkinson's disease. 114
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 114
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 114
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 113
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 112
Heat shock protein 70: implication for Alzheimer's disease 111
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 111
Olanzapina: il nuovo trattamento della Sindrome di Gilles de La Tourette 110
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 110
Mitochondrial Involvement in Neurodegenerative Dementia 109
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 108
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 108
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 108
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 108
P3 topography in brain lesions 107
Neurite ottica: relazione tra perimetria, PEV e RMN 107
Pathological Gambling in PD is reduced by Amantadine 107
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 107
3D localization of interictal epileptic activity by neuromagnetic method 106
Atrofia Multisistemica: approccio diagnostico multidisciplinare 106
Catamenial end-off dose in Parkinson's disease 106
Are VEP abnormalities in optic neuritis (ON) dependent on plaque size? A reappraisal of the physiopathology of ON based on improved MRI and multiple-lead recordings. 105
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 105
Altitudinal visual stimuli and the cruciform model of evoked potentials. 104
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism 104
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study 104
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 104
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 103
Donepezil vs vitamina E nella malattia di Alzheimer (AD): confronto tra P300 Event Related Potential e Test Neuropsicologici. 102
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 102
Registrazioni dei potenziali evocati visivi ed evento_correlati in un paziente affetto da sindrome di Balint 101
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 101
AMANTADINE EFFECT ON PARKINSON'S DISEASE IMPULSE CONTROL DISORDER 101
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 101
Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies. 101
Acute akinesia in Parkinson disease. 101
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 100
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 100
PSI proteasome inhibitor induced rat model of Parkinson’s Disease. 100
Polymorphisms of chemokine receptor genes in Alzheimer's and Parkinson's Patients 99
L’ecografia transcranica nello studio del parenchima cerebrale: la nostra casistica 99
The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study 99
Paradoxical kinesia in parkinsonian patients surviving earthquake. 99
A stage-based approach to therapy in parkinson’s disease 99
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. 98
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 98
Attivazione dell'emisfero non-dominante in giocatori di scacchi durante la soluzione di complessi problemi strategici 97
Cohort study on tremor in DLB: prevalence and features 97
Unsuccessful switch over from clozapine to olanzapine after clozapine-induced granulocytopenia in three psychotic Parkinson's disease patients 96
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. 96
Long time echo STIR sequence magnetic resonance imaging of optic nerves in optic neuritis. 96
Camptocormia in Lewy Body Disease (LBD) in comparison with Parkinson’s Disease (PD). 96
Camptocormia in Lewy body disease (LBD) in comparison with Parkinson's disease (PD) 96
Cortical rhythms in ad, lbd and normal subjects: a quantitative MEG study 95
Uso della amantadina nel trattamento delle discinesie e fluttuazioni motorie in pazienti affetti da Morbo di Parkinson 95
Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study 95
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 95
Fisiopatologia della neurite ottica: correlazioni cliniche, elettrofisiologiche e neuroradiologiche 94
Totale 12.349
Categoria #
all - tutte 100.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021914 0 0 0 0 0 351 42 31 74 216 111 89
2021/20221.082 27 25 27 129 60 31 26 95 71 46 175 370
2022/20233.715 301 430 246 390 366 759 240 244 492 55 89 103
2023/20241.714 133 75 124 85 92 432 429 52 37 63 29 163
2024/20254.251 266 717 618 126 103 156 100 241 340 260 437 887
2025/20264.596 840 336 992 1.226 799 403 0 0 0 0 0 0
Totale 25.458